Related Experiment Video
Updated: Aug 17, 2026

Habituation and Prepulse Inhibition of Acoustic Startle in Rodents
Published on: September 1, 2011
Reduction of blood platelet monoamine oxidase activity in schizophrenic patients on phenothiazines
Abstract:
A newly developed assay for monoamine oxidase (MAO) activity in blood platelets (serotonin used as substrate) was applied for the measurement of the enzyme activity in 76 schizophrenic patients. No significant reduction was found in the blood platelet MAO activity in a group of 33 untreated schizophrenic patients, as compared to that in the normal controls. Male patients revealed to have lower enzyme activity than females in the schizophrenic group, as we described previously in the normal subjects. Treatment with phenothiazines caused significant reduction of blood platelet MAO activity, while platelet serotonin content and platelet count appeared to be not affected by the drug treatment. The authors suggest that blood platelet MAO activity may be related to hormonal factors but not to psychiatric diagnosis of schizophrenia or constitution liable to schizophrenic illnesses.
Insights
Blood platelet monoamine oxidase (MAO) activity was measured in schizophrenic patients. Untreated patients showed no significant MAO reduction, suggesting MAO levels are not linked to schizophrenia diagnosis.
Area of Science:
- Neuroscience
- Biochemistry
Background:
- Monoamine oxidase (MAO) plays a crucial role in neurotransmitter metabolism.
- Altered MAO activity has been implicated in various psychiatric disorders.
Purpose of the Study:
- To investigate blood platelet monoamine oxidase (MAO) activity in schizophrenic patients.
- To determine if MAO activity is associated with schizophrenia diagnosis or treatment.
Main Methods:
- A newly developed assay was used to measure MAO activity in blood platelets using serotonin as a substrate.
- MAO activity was assessed in 76 schizophrenic patients (33 untreated) and compared to normal controls.
Main Results:
- No significant reduction in blood platelet MAO activity was observed in untreated schizophrenic patients compared to controls.
- Male schizophrenic patients exhibited lower MAO activity than females, consistent with findings in normal subjects.
- Phenothiazine treatment significantly reduced platelet MAO activity, without affecting platelet serotonin content or count.
Conclusions:
- Blood platelet MAO activity does not appear to be directly related to the psychiatric diagnosis of schizophrenia.
- MAO activity may be influenced by hormonal factors rather than a predisposition to schizophrenia.
- Phenothiazine treatment impacts MAO activity, highlighting a potential therapeutic mechanism.
Related Concept Videos
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Goals of Pharmacotherapy
Antipsychotic Drugs: Typical and Atypical Agents
Antidepressant Drugs: MAOIs and Other Agents
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...

